Results 171 to 180 of about 37,528 (237)

Repurposing SARS CoV 2 ligands identifies salvianolic acid C as potential antiviral candidate against human metapneumovirus through computational study. [PDF]

Sci Rep
Shanthappa PM, Melethadathil N, Kollur SP.   +2 more
europepmc   +1 more source

Epidemiology and Burden of Human Metapneumovirus Among Italian Adults in Outpatient and Inpatient Settings, 2014-2025. [PDF]

Influenza Other Respir Viruses
Domnich A, Panatto D, Paolozzi V, Ogliastro M, Ricucci V, Icardi G, Orsi A.   +6 more
europepmc   +1 more source

<i>SEC11A</i> identified as a critical host factor for HMPV through virus-induced alternative splicing. [PDF]

Biosaf Health
Huang Y, Guo J, Zheng S, Chen A, Yao L, Zhang K, Zheng L.   +6 more
europepmc   +1 more source

Severe Manifestations of Human Metapneumovirus With Co-infections: A Case Series and Literature Review. [PDF]

Cureus
Aradhana, Mishra V, Rup AR, Mohakud NK.
europepmc   +1 more source

Trends of Human Metapneumovirus Outbreaks in Bangladesh: Probable Risks and Preventive Strategies. [PDF]

Health Sci Rep
Sharif N, Dey SK.
europepmc   +1 more source

Human Metapneumovirus

, 2023
openaire   +3 more sources

Case Report: Unusual radiological findings in adult human metapneumovirus infection. [PDF]

Front Med (Lausanne)
Jiun LC, Yee HS, Azmi MI.
europepmc   +1 more source

Correction: Immunoinformatic design of chimeric multiepitope vaccine for the prevention of human metapneumovirus (hMPV). [PDF]

BMC Infect Dis
Ehsasatvatan M, Kohnehrouz BB, Salavatizadeh M.   +2 more
europepmc   +1 more source